Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FWJYM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,402
Award facts
- Contract value 100% obligated
- $11,401.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format, with a ceiling value of $11,401.57. This is a firm fixed price, non-set-aside delivery order under a larger Indefinite Delivery Contract (IDC) vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The place of performance is listed as Conshohocken, PA, where the company maintains its corporate operations.
This delivery order represents a single transaction within AmerisourceBergen's broader $999.99 billion DLA Troop Support Medical IDC (SPE2DX), which runs through December 2026 and provides global pharmaceutical support for military healthcare programs. The company's extensive federal contract portfolio demonstrates capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications and biologics like Cosentyx, a TNF-alpha inhibitor used to treat autoimmune conditions. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen supplies branded and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support worldwide military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWJYM?
SPE2DB25FWJYM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWJYM worth?
The government has obligated $11,402 on SPE2DB25FWJYM.
Is contract SPE2DB25FWJYM an order under another contract?
Yes. SPE2DB25FWJYM is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJYM competed?
The extent of competition for SPE2DB25FWJYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award